EEDi-5285
EEDi-5285 is an exceptionally potent and orally active embryonic ectoderm development (EED) inhibitor with an IC50 value of 0.2 nM for binds to the EED protein. EEDi-5285 has anti-cancer activity[1].
Product Specifications
CAS Number
[2488952-40-3]
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/eedi-5285.html
Purity
99.87
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CS(C1=C2C(C3=CC=C(C4CC4)N=C3)=CN=C(NCC5=C(F)C=CC6=C5CCO6)N2C=N1)(=O)=O
Molecular Formula
C24H22FN5O3S
Molecular Weight
479.53
References & Citations
[1]Rohan Kalyan Rej, et al. EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development. J Med Chem. 2020 Jul 9;63 (13) :7252-7267.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6296737-01 0.2 mL
ESCO2, ID (ESCO2, N-acetyltransferase ESCO2, Establishment of cohesion 1 homolog 2) (FITC)
Ask
View Details 
MBS6296737-02 5x 0.2 mL
ESCO2, ID (ESCO2, N-acetyltransferase ESCO2, Establishment of cohesion 1 homolog 2) (FITC)
Ask
View Details 
MBS1102791-01 0.02 mg (E-Coli)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details MBS1102791-02 0.1 mg (E-Coli)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details MBS1102791-03 0.02 mg (Yeast)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details